Epidemiological screening and detection indicators for hepatitis D and suitable populations
10.3969/j.issn.1001-5256.2023.04.006
- VernacularTitle:丁型肝炎流行病学筛查检测指标及适宜人群
- Author:
Xiumei CHI
1
;
Junqi NIU
2
Author Information
1. Gene Therapy Laboratory, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun 130061, China
2. Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun 130021, China
- Publication Type:Discussions by Experts
- Keywords:
Hepatitis Delta Virus;
Epidemiology;
Diagnostic Techniques and Procedures
- From:
Journal of Clinical Hepatology
2023;39(4):771-775
- CountryChina
- Language:Chinese
-
Abstract:
Hepatitis D virus (HDV) infection requires the participation of hepatitis B virus (HBV), which accelerates disease progression after infection and induces a high risk of progression to end-stage liver diseases such as liver cirrhosis and liver cancer. With the gradual increase in the understanding of hepatitis D in the whole society, some therapeutic drugs for hepatitis D have become a research hotspot in recent years, and with the further improvement in clinical testing methods, researchers have started to pay attention to the epidemiological investigation of hepatitis D. Although many studies have been conducted for the specific situation of HDV infection in China, large data deviation is observed due to small cohorts with strong regional features. This article briefly reviews the population, methods, and indicators in the current epidemiological investigation of hepatitis D and discusses related key issues, in order to obtain more accurate epidemiological data, effectively screen out HDV infection, and provide help for early clinical intervention and treatment.
